US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 26, 2017 (9 years ago)

Methocarbamol

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Lack of quality assurance at the API manufacturer.

What was recalled

Methocarbamol, USP, packaged in a) 100 g container (NDC: 58597-8023-6, b) 500 g container (NDC: 58597-8023-7), c) 1,000 g container (NDC: 58597-8023-8). For Prescription Compounding RX Only. Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Recalling firm
American Pharmaceutical Ingredients LLC
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0937-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Methocarbamol recalls

See all
Class II · Moderate risk Ongoing

Methocarbamol Injection USP 1

Reason Lack of Assurance of Sterility: Media fill with bacterial contamination

Somerset Therapeutics Private Limited NDC 70069-101-25 D-0354-2025
Class I · High risk Ongoing

Methocarbamol Injection

Reason Presence of Particulate Matter

Eugia US LLC NDC 55150-223-10 D-0440-2024
Class I · High risk Completed

Methocarbamol 500mg Tablet

Reason Labeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol 500 mg Tablets actually contain Methocarbamol 750 mg Tablets

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0092-2022
Class II · Moderate risk Terminated

Methocarbamol 500mg 500

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0406-2021
Class II · Moderate risk Terminated

Methocarbamol liquid 100mg/ml

Reason Lack of sterility assurance.

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0400-2019